FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Diflunisal Tablets
Status: Currently in Shortage
»Date first posted: 02/25/2022
»Therapeutic Categories: Analgesia/Addiction

Expand all

Avet Pharmaceuticals, Inc. (formerly Heritage Pharma) (Revised 04/13/2022)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, Bottle of 60 (NDC 14539-673-06) Product is on backorder and should be available end of April 2022 Delay in manufacturing
500 mg, Bottle of 100 (NDC 14539-673-01) Product is on backorder and should be available end of April 2022 Delay in manufacturing

Teva Pharmaceuticals (Reverified 04/29/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
500 mg, Bottle of 100 (NDC 0093-9222-01) Unavailable/Estimated recovery May 2022 Other
500 mg, Bottle of 500 (NDC 0093-9222-05) Unavailable/Estimated recovery May 2022 Other
500 mg, Bottle of 60 (NDC 0093-9222-06) Unavailable/Estimated recovery May 2022 Other

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English